Inhibition of Human Immunodeficiency Virus Type 1 Long Terminal Repeat-Driven Transcription by an in Vivo Metabolite of Oltipraz: Implications for Antiretroviral Therapy

Author: Prochaska H.J.   Fernandes C.L.   Pantoja R.M.   Chavan S.J.  

Publisher: Elsevier

ISSN: 0006-291X

Source: Biochemical and Biophysical Research Communications, Vol.221, Iss.3, 1996-04, pp. : 548-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content